These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 17593641)

  • 1. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
    Agrawal CS; Chalise PR; Bhandari BB
    Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
    Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
    Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
    Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
    J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.
    Arai Y; Aoki Y; Okubo K; Maeda H; Terada N; Matsuta Y; Maekawa S; Ogura K
    J Urol; 2000 Oct; 164(4):1206-11. PubMed ID: 10992367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
    Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
    J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
    Zhao Z; Wang G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
    Shao Q; Song J; Guo YW; Lu WC; Du LD
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
    Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
    BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
    Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
    Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)].
    de la Taille A; Desgrandchamps F; Haillot O; Saussine C; Lukacs B; Marc F;
    Prog Urol; 2006 Nov; 16(5):568-71. PubMed ID: 17175953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.